1.Association of neutrophil gelatinase-associated lipocalin and severity of coronary stenosis in patients with stable coronary artery disease
Li ZHU ; Minghao HE ; Meili ZHOU ; Shengchao WANG ; Kun CHEN
China Modern Doctor 2024;62(23):57-62
		                        		
		                        			
		                        			Objective To investigate the association of neutrophil gelatinase-associated lipocalin(NGAL)and severity of coronary stenosis in patients with stable coronary artery disease(SCAD).Methods Totally 144 patients who underwent coronary angiography firstly due to suspected coronary artery disease were enrolled.The patients were divided into SCAD group(n=101)and non-CAD group(n=43),and the clinical data were compared.The SCAD group was fuether divided into three subgroups accoding to Gensini score:mild stenosis group(Gensini<16,n=32),moderate stenosis(16≤Gensini<30,n=33)and severe stenosis group(Gensini≥36,n=35).The clinical data of each group were compared.Odinal Logistic regression was used to analysis the influencing factors of severe stenosis.The receiver operating characteristic(ROC)curve was performed to evaluated the ability of NGAL in discriminating severe stenosis.Results Serum NGAL,high sensitive C-reactive protein(hs-CRP)level in SCAD group were higher than those in non-CAD group(P<0.01).Comparing with mild and moderate stenosis groups,NGAL and hs-CRP level were more higher in severe stenosis group(P<0.01).Multivariable Logistic regression analysis showed that NGAL and hs-CRP were independent risk factors for severe coronary stenosis(both P<0.05).Receiver operating characteristic(ROC)curve analysis showed that the areas under the curve of NGAL and hs-CRP were 0.771,0.702 respectively(both P<0.01).The difference between two AUCs was 0.069 which was insignificant(P>0.05).Conclusion Serum NGAL increased is closely associated with severe coronary stenosis in patients with SCAD,which has a certain ability of discriminating severity of coronary stenosis.
		                        		
		                        		
		                        		
		                        	
2.Chronic intermittent hypoxia impairs learning and memory by upregulating HMGB1 and NF-κB in rat hippocampus
Zhengang WU ; Yao XIAO ; Yafang CHEN ; Jinying ZHANG ; Zeming GUO ; Jun LIN ; Meili YANG
Chinese Journal of Neuroanatomy 2024;40(2):224-230
		                        		
		                        			
		                        			Objective:To explore the effect of chronic intermittent hypoxia(CIH)on learning and memory dysfunc-tion in rats,as well as the expression of high mobility group box-1(HMGB1)and nuclear transcription factor-KB(NF-κB)in the hippocampus region.Methods:The CIH rat model was established,and forty SD rats were randomly divid-ed into four groups:normoxia group,hypoxia for 4 weeks group(CIH4 group),hypoxia for 8 weeks group(CIH8 group),and hypoxia for 12 weeks group(CIH12 group).Morris water maze was used to assess the learning memory ability of rats,and immunohistochemistry and ELISA were used to detect the expression of HMGB1 and NF-κB in the hippocampus of rats.Results:Compared with the normoxia group,the CIH12 and CIH8 groups had longer escape la-tency,the number of crossing the platform and the residence time in the quadrant of the platform were significantly shortened,but there was no significant difference in the CIH4 group.Additionally,there was no significant expression of HMGB1 and NF-κB in the hippocampal region of the normoxia group,but little expression was observed in CIH4 group,and significantly expressed in CIH8 group and CIH12 group,and the expression of CIH12 group was significantly higher than that of CIH8 group.Conclusion:CIH can lead to a decline in learning and memory function in rats,and the longer time of intermittent hypoxia led to the more significant effect on their learning and memory function.In addi-tion,CIH also leads to increased expression levels of HMGB1 and NF-κB in the hippocampus region,and the expres-sion increased more significantly after hypoxia for 12 weeks,comparing to hypoxia for 8 weeks.
		                        		
		                        		
		                        		
		                        	
3.Clinical and genetic analysis of essential hypertension with mitochondrial tRNAMet 4435A>G and YARS2 mutation
Meili GUO ; Yunfan HE ; Ade CHEN ; Zaishou ZHUANG ; Xiaoyong PAN ; Minxin GUAN
Journal of Zhejiang University. Medical sciences 2024;53(2):184-193
		                        		
		                        			
		                        			Objective:To investigate the role of m.4435A>G and YARS2 c.572G>T(p.G191V)mutations in the development of essential hypertension.Methods:A hypertensive patient with m.4435A>G and YARS2 p.G191V mutations was identified from previously collected mitochondrial genome and exon sequencing data.Clinical data were collected,and a molecular genetic study was conducted in the proband and his family members.Peripheral venous blood was collected,and immortalized lymphocyte lines constructed.The mitochondrial transfer RNA(tRNA),mitochondrial protein,adenosine triphosphate(ATP),mitochondrial membrane potential(MMP),and reactive oxygen species(ROS)in the constructed lymphocyte cell lines were measured.Results:Mitochondrial genome sequencing showed that all maternal members carried a highly conserved m.4435A>G mutation.The m.4435A>G mutation might affect the secondary structure and folding free energy of mitochondrial tRNA and change its stability,which may influence the anticodon ring structure.Compared with the control group,the cell lines carrying m.4435A>G and YARS2 p.G191V mutations had decreased mitochondrial tRNA homeostasis,mitochondrial protein expression,ATP production and MMP levels,as well as increased ROS levels(all P<0.05).Conclusion:The YARS2 p.G191V mutation aggravates the changes in mitochondrial translation and mitochondrial function caused by m.4435A>G through affecting the steady-state level of mitochondrial tRNA and further leads to cell dysfunction,indicating that YARS2 p.G191V and m.4435A>G mutations have a synergistic effect in this family and jointly participate in the occurrence and development of essential hypertension.
		                        		
		                        		
		                        		
		                        	
4.Investigation and control of a suspected outbreak of healthcare acquired infection caused by carbapen-em-resistant klebsiella pneumonia in intensive care unit of neurology department
Shuqi WANG ; Ping ZHOU ; Meili ZHOU ; Dongqin CHEN
Modern Hospital 2024;24(7):1130-1133
		                        		
		                        			
		                        			Objective To investigate the cause of a suspected outbreak of carbapenem-resistant Klebsiella pneumoniae infection(CRKP)in the neurological ICU,to find out the reason for infection and the way of transmission to provide evidence for the prevention and control of nosocomial infection.Methods Four patients with CRKP infection in the department of neurological ICU of a hospital from Au-gust 4 to August 20,2020 were investigated epidemiologically and environmental hygiene monitoring of the ward was carried out.Compre-hensive measures were taken to control the outbreak.Results All four CRKP infection cases were hospital-acquired,and the isolated strains showed consistent drug susceptibility test results,indicating they were the same clone.Environmental hygiene monitoring revealed the presence of the same clone in samples from patient bedside items,suction devices,oxygen therapy equipment,and personal belongings of healthcare workers.After implementing comprehensive corrective measures,no new cases of CRKP infection occurred,and subsequent surface sampling did not isolate any CRKP strains.Conclusion Environmental surface contamination in the neurointensive care unit and inadequate disinfection procedures were likely the main causes of the suspected outbreak of CRKP infection.Prompt identification of the outbreak,activation of emergency response plans,and implementation of corrective measures are crucial for controlling the outbreak of multidrug-resistant bacterial infections in hospitals.After adopting comprehensive measures,there were no new CRKP infection cases.
		                        		
		                        		
		                        		
		                        	
5.Pharmacological Interventions for Cirrhotic Ascites: From Challenges to Emerging Therapeutic Horizons
Yuan GAO ; Xin LIU ; Yunyi GAO ; Meili DUAN ; Bing HOU ; Yu CHEN
Gut and Liver 2024;18(6):934-948
		                        		
		                        			
		                        			 Ascites is the most common complication in patients with decompensated cirrhosis. This condition results in a severely impaired quality of life, excessive healthcare use, recurrent hospitalizations and significant morbidity and mortality. While loop diuretics and mineralocorticoid receptor antagonists are commonly employed for symptom relief, our understanding of their impact on survival remains limited. A comprehensive understanding of the underlying pathophysiological mechanism of ascites is crucial for its optimal management. The renin-angiotensin-aldosterone system (RAAS) is increasingly believed to play a pivotal role in the formation of cirrhotic ascites, as RAAS overactivation leads to a reduction in urine sodium excretion then a decrease in the ability of the kidneys to excrete water. In this review, the authors provide an overview of the pathogenesis of cirrhotic ascites, the challenges associated with current pharmacologic treatments, and the previous attempts to modulate the RAAS, followed by a description of some emerging targeted RAAS agents with the potential to be used to treat ascites. 
		                        		
		                        		
		                        		
		                        	
6.Pharmacological Interventions for Cirrhotic Ascites: From Challenges to Emerging Therapeutic Horizons
Yuan GAO ; Xin LIU ; Yunyi GAO ; Meili DUAN ; Bing HOU ; Yu CHEN
Gut and Liver 2024;18(6):934-948
		                        		
		                        			
		                        			 Ascites is the most common complication in patients with decompensated cirrhosis. This condition results in a severely impaired quality of life, excessive healthcare use, recurrent hospitalizations and significant morbidity and mortality. While loop diuretics and mineralocorticoid receptor antagonists are commonly employed for symptom relief, our understanding of their impact on survival remains limited. A comprehensive understanding of the underlying pathophysiological mechanism of ascites is crucial for its optimal management. The renin-angiotensin-aldosterone system (RAAS) is increasingly believed to play a pivotal role in the formation of cirrhotic ascites, as RAAS overactivation leads to a reduction in urine sodium excretion then a decrease in the ability of the kidneys to excrete water. In this review, the authors provide an overview of the pathogenesis of cirrhotic ascites, the challenges associated with current pharmacologic treatments, and the previous attempts to modulate the RAAS, followed by a description of some emerging targeted RAAS agents with the potential to be used to treat ascites. 
		                        		
		                        		
		                        		
		                        	
7.Pharmacological Interventions for Cirrhotic Ascites: From Challenges to Emerging Therapeutic Horizons
Yuan GAO ; Xin LIU ; Yunyi GAO ; Meili DUAN ; Bing HOU ; Yu CHEN
Gut and Liver 2024;18(6):934-948
		                        		
		                        			
		                        			 Ascites is the most common complication in patients with decompensated cirrhosis. This condition results in a severely impaired quality of life, excessive healthcare use, recurrent hospitalizations and significant morbidity and mortality. While loop diuretics and mineralocorticoid receptor antagonists are commonly employed for symptom relief, our understanding of their impact on survival remains limited. A comprehensive understanding of the underlying pathophysiological mechanism of ascites is crucial for its optimal management. The renin-angiotensin-aldosterone system (RAAS) is increasingly believed to play a pivotal role in the formation of cirrhotic ascites, as RAAS overactivation leads to a reduction in urine sodium excretion then a decrease in the ability of the kidneys to excrete water. In this review, the authors provide an overview of the pathogenesis of cirrhotic ascites, the challenges associated with current pharmacologic treatments, and the previous attempts to modulate the RAAS, followed by a description of some emerging targeted RAAS agents with the potential to be used to treat ascites. 
		                        		
		                        		
		                        		
		                        	
8.Pharmacological Interventions for Cirrhotic Ascites: From Challenges to Emerging Therapeutic Horizons
Yuan GAO ; Xin LIU ; Yunyi GAO ; Meili DUAN ; Bing HOU ; Yu CHEN
Gut and Liver 2024;18(6):934-948
		                        		
		                        			
		                        			 Ascites is the most common complication in patients with decompensated cirrhosis. This condition results in a severely impaired quality of life, excessive healthcare use, recurrent hospitalizations and significant morbidity and mortality. While loop diuretics and mineralocorticoid receptor antagonists are commonly employed for symptom relief, our understanding of their impact on survival remains limited. A comprehensive understanding of the underlying pathophysiological mechanism of ascites is crucial for its optimal management. The renin-angiotensin-aldosterone system (RAAS) is increasingly believed to play a pivotal role in the formation of cirrhotic ascites, as RAAS overactivation leads to a reduction in urine sodium excretion then a decrease in the ability of the kidneys to excrete water. In this review, the authors provide an overview of the pathogenesis of cirrhotic ascites, the challenges associated with current pharmacologic treatments, and the previous attempts to modulate the RAAS, followed by a description of some emerging targeted RAAS agents with the potential to be used to treat ascites. 
		                        		
		                        		
		                        		
		                        	
9.Glycyrrhizic acid⁃mediated protective effect of miRNAs on alcoholic liver inj ury in rats
Meili Cong ; Mayire Nuermaimaiti ; Bei Zhou ; Ruihua Chen ; Zhong Wang ; Huhu Zhu ; Xiaoguo Zhao
Acta Universitatis Medicinalis Anhui 2023;58(8):1374-1379
		                        		
		                        			Objective     :
		                        			To  investigate  the  mechanism of miRNAs  in  glycyrrhizic  acid treatment of alcohol⁃induced
liver injury in rats .  
		                        		
		                        			Methods    :
		                        			45  male  SD rats  were  randomly divided into glycyrrhizin group ,   model  group  and control group .  The rats in glycyrrhizin group were given 56%  liquor and  glycyrrhizin ,  the rats in model group were
given 56%  liquor ,  and the rats  in control group were given distilled water for 8 weeks . The blood was collected and the serum was separated by centrifugation to detect the levels of aspartate aminotransferase  (AST)  and alanine aminotransferase  (ALT) .   RNA  were  extracted  from  liver  tissues ,  miRNAs  were  detected  by  rat  miRNA  microarray , and their expression levels  were  analyzed .   The  miRNA  target  genes  of  differential  miRNA  were  predicted .    Gene Ontology  (GO)  and KEGG Pathway enrichment analysis were  used to understand the function of differential miRNA ,  and  the  differential  miRNA⁃mRNA⁃Pathway  regulatory  network  was  constructed  using  Cytoscape  to  further screen the regulatory key miRNA and key pathways .   qRT⁃PCR was used to verify the expression of selected miRNA .
		                        		
		                        			Results      :
		                        			 Compared  with the  model group ,  the  glycyrrhizin  group  could  significantly  improve  the  liver  tissue lesions ,  and  reduce the liver serum AST and ALT levels  (P < 0. 05) .   Compared the microarray data of glycyrrhizin group and model group ,  a total  of 13  differentially  expressed  miRNA  were  screened  ( P  < 0. 05 ,  fold  change   ≥ 1 . 5) ,  of which  10  were  up⁃regulated  and  3  were  down⁃regulated .   The  GO  classification  annotation  of differential miRNA target genes showed that differential miRNA were related to cell adhesion ,  antioxidant activity ,  metabolic process ,  biological process regulation ,  cell killing ,  immune  system and other functions .  The KEGG Pathway analyling pathway ,  Hippo  signaling pathway ,  PI3K⁃Akt  signaling  pathway ,  wnt  signaling  pathway ,  apoptosis  and  other signaling pathways might play an important regulatory role in the improvement of alcoholic liver injury by glycyrrhic acid .  
		                        		
		                        			Conclusion     
		                        			This  study established the miRNA expression profile of glycyrrhizin in the treatment of alcoholic liver injury in rats ,  suggested that miR⁃615 ,  miR⁃107 ⁃3p  and  miR⁃292⁃5p  might  play  an  important role  in  the treatment of alcoholic liver injury by glycyrrhizin .
		                        		
		                        		
		                        		
		                        	
10.Establishment and performance evaluation of Der p 1/Der p 2 specific immunoglobulin E detection for the components of dust mite allergens based on chemiluminescence immunoassay
Feifei HAN ; Ying ZHOU ; Jian ZHANG ; Hao YIN ; Meili WU ; Xi CHEN ; Yubao CUI
Chinese Journal of Nuclear Medicine and Molecular Imaging 2022;42(3):160-164
		                        		
		                        			
		                        			Objective:To establish a quantitative detection method for the main components of dust mite allergens Der p 1, Der p 2 specific immunoglobulin E (sIgE) by using the nano-magnetic particle chemiluminescence immunoassay.Methods:The performance indexes of the established method were evaluated after setting up and optimizing the chemiluminescence detection system and immune reaction conditions of sIgE for dust mite allergen. Serum sIgE levels of 50 suspected allergic patients with dust mite were determined by this chemiluminescence method. At the same time, this method was compared with the Phadia kit and the consistency was analyzed by Kappa test. Results:The optimal amount of magnetic beads was 25 μg, the optimal reaction buffer (pH=7.4) contained 0.1 mol/L Tris-HCl and 0.25%( W/ W) casein, the optimal coating solution contatined 20 mmol/L phosphate buffer (PB) and 1%( W/ W) bovine serum albumin (BSA), and the luminescence enhancement solution contained 0.05%( V/ V) Triton X-100. The two-step immunoreaction was adopted, and the detection could be completed with 20 μl sample at the optimal reaction temperature of 37℃. The limit of detection (LOD) of the established nano-magnetic particle chemiluminescence system in detecting Der p 1 and Der p 2 sIgE antibodies were both less than 0.01 kU/L, with the linear range of 0.2-100.0 kU/L, the precision of less than 7%, and the cross contamination rate of 0.19% and 0.21%. Compared with the Phadia system, the positive and negative coincidence rate of Der p 1 were 78.0%(32/41) and 9/9 with good consistency ( Kappa=0.65, P=0.008), and the positive and negative coincidence rate of Der P 2 were 93.3%(28/30) and 85.0%(17/20) with good consistency ( Kappa=0.79, P=0.003). Conclusion:The nano-magnetic particle chemiluminescence immunoassay is successfully established for detecting dust mite allergen sIgE, which has good detection performance and good consistency with Phadia system.
		                        		
		                        		
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail